Topics

Aytu BioScience, Inc.: Aytu BioScience Announces Definitive Agreement to Acquire Innovus Pharmaceuticals

08:08 EDT 12 Sep 2019 | FinanzNachrichten

Acquisition Gives Aytu Timely Entry into Growing Consumer Healthcare Market with a Portfolio of Over 30 Products that Generated $24M of Revenue During Past Four Quarters Combination Will Create Spe...

Original Article: Aytu BioScience, Inc.: Aytu BioScience Announces Definitive Agreement to Acquire Innovus Pharmaceuticals

NEXT ARTICLE

More From BioPortfolio on "Aytu BioScience, Inc.: Aytu BioScience Announces Definitive Agreement to Acquire Innovus Pharmaceuticals"

Quick Search

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...